APA (7th ed.) Citation

Yamashita, H., Kitayama, J., Kanno, N., Yatomi, Y., & Nagawa, H. (2006). Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer, 6, 147. https://doi.org/10.1186/1471-2407-6-147

Chicago Style (17th ed.) Citation

Yamashita, Hiroharu, Joji Kitayama, Nobuko Kanno, Yutaka Yatomi, and Hirokazu Nagawa. "Hyperfibrinogenemia Is Associated with Lymphatic as Well as Hematogenous Metastasis and Worse Clinical Outcome in T2 Gastric Cancer." BMC Cancer 6 (2006): 147. https://doi.org/10.1186/1471-2407-6-147.

MLA (9th ed.) Citation

Yamashita, Hiroharu, et al. "Hyperfibrinogenemia Is Associated with Lymphatic as Well as Hematogenous Metastasis and Worse Clinical Outcome in T2 Gastric Cancer." BMC Cancer, vol. 6, 2006, p. 147, https://doi.org/10.1186/1471-2407-6-147.